Iron Horse Acquisitions Corp. (NASDAQ: IROH) announced the pricing of its upsized $61 million IPO this morning. Its units are expected to begin trading on the Nasdaq under the symbol “IROHU” on Wednesday, December 27, 2023. After the securities comprising the units begin separate trading, the Class A ordinary shares, warrants, and rights are expected to be listed on the Nasdaq under the symbols “IROH,” “IROHW,” and “IROHR,” respectively.
The company intends to initially focus on target companies within the media & entertainment industry with a primary focus on the United States. Iron Horse is led by CEO Jose Antonio Bengochea, Chairman Brian Turner, CFO Jane Waxman, and COO William Caragol.
Total SPAC deal count for 2023 year-to-date is now 31. This offering is expected to close on Friday, December 29, 2023.
EF Hutton LLC, is acting as sole book-running manager in the offering. Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as co-manager in the offering. Zarren Law Group, LLC is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. MaloneBailey, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
At the SPAC of Dawn Amid a restive market, SPACs have front-loaded their business this week with three of their four votes set for today and tomorrow. One of these is a completion vote, in which Bowen (NASDAQ:BOWN) will try and secure shareholder approval for its combination with Shenzhen Qianzhi BioTechnology just after having gained...
Terms Tracker for the Week Ending January 10, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was the first full week in January and the first non-holiday week since December 23rd. All the same, 2025 has started with a bang...
Origin Investment Corp I has filed for a $60 million SPAC to hunt for an Asian target outside of China and marks ThinkEquity’s entry into the 2025 SPAC IPO market. ThinkEquity took all of 2024 off from directly underwriting SPACs as a left lead and has not brought one all the way to IPO since...
Rarely does a group of companies go through a complete industry-defining roller coaster in a matter of weeks based on the comments of two CEOs not of their direct subsector, but that is exactly the kind of winter that quantum computing companies are having. And, despite the recent valley that followed the spike, the three...
At the SPAC of Dawn The markets return from their short funeral break still in the red, but the 8:30 am ET dropping of employment and wage indicators could make this a harder or softer return to business. Drugs Made In America (NASDAQ:DMAAU) is expected to make its debut during this session as the year’s...